Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000494:pharmacology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology
D004273:DNA, Neoplasm; D003841:Deoxycytidine; D010770:Phosphotransferases; D014740:Vidarabine; C024352:fludarabine